Search - tctmd.com

Displaying 921 - 940 of 1057

Sort: Relevancy | Date

Presentation TCT 2013

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Expansion of Primary PCI Hospitals to Broaden the STEMI Net: Right Idea, Misguided Implementation?

Presenter: Gregory Dehmer

October 30, 2013

Presentation TCT 2013

BVS in STEMI: Challenges and Pitfalls (With Case Examples)

Presenter: Philippe Généreux

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

Presentation TCT 2013

Update on ADSCs and MPCs for STEMI

Presenter: Henricus Duckers

October 29, 2013

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Presentation TCT 2013

Case #1: A Complex PCI Using Radial Access in STEMI

Presenter: Zolt?n Jambrik

October 29, 2013

Presentation TCT 2013

TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI.

Presenter: Huangling Lu

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

Presenter: Albert Alahmar

October 29, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation TCT 2013

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Presenter: Alejandro Fernandez

October 29, 2013

Presentation TCT 2013

Allogeneic Cardiac-Derived Cells for STEMI

Presenter: Raj Makkar

October 29, 2013

News Conference News TCT 2013

Intraprocedural ST Predicts Adverse Short-Term Events

October 29, 2013

Presentation TCT 2013

Stop the Debate! DES Have Been Proven Safe and Effective in STEMI

Presenter: Tullio Palmerini

October 28, 2013

Advertisement

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Expansion of Primary PCI Hospitals to Broaden the STEMI Net: Right Idea, Misguided Implementation?

BVS in STEMI: Challenges and Pitfalls (With Case Examples)

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Update on ADSCs and MPCs for STEMI

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Case #1: A Complex PCI Using Radial Access in STEMI

TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI.

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Allogeneic Cardiac-Derived Cells for STEMI

Intraprocedural ST Predicts Adverse Short-Term Events

Stop the Debate! DES Have Been Proven Safe and Effective in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content